Literature DB >> 17280837

The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation.

Christos Alexiou1, George Doukas, Mehmet Oc, Bahar Oc, Justiaan Swanevelder, Nilesh J Samani, Tomasz J Spyt.   

Abstract

OBJECTIVE: There is conflicting evidence with regard to the impact of preoperative atrial fibrillation (AF) on the post mitral valve (MV) repair on the early and late outcome.
METHODS: A total of 349 patients undergoing various MV repair procedures for degenerative mitral regurgitation (MR) between 1997 and 2003 were studied. Preoperatively, 152 (44%) of these patients were in AF and 197 (56%) patients were in sinus rhythm (SR). The clinical features and the outcome in these two cohorts of patients were compared.
RESULTS: The patients in the AF group were older than their counterparts in the SR group (66+/-7 vs 62+/-9 years) (p=0.01), had a higher mean NYHA class score (2.4+/-0.6 vs 2.2+/-0.7) (p=0.04) and were more likely to have impaired left ventricular function (60% vs 36%) (p<0.0001). A similar proportion of patients in the AF (38%) and SR (30%) groups had additional cardiac surgical procedures (p=0.12). Operative mortality was 3.9% in AF group versus 0.5% in SR group (p=0.04), and operative morbidity was 27% versus 17%, respectively (p=0.03). At latest follow up, 4% of patients that were in SR preoperatively developed AF; conversely, 2% of the patients in the AF group converted to SR. The rates of recurrent grade II or III MR (4% vs 5%) (p=0.8) and MV re-operation (2.6% vs 2.5%) (p=1.0) were similar in the AF and SR groups. Kaplan-Meier survival at 7 years was 75+/-6% versus 90+/-3% (p=0.005). On Cox proportional hazards regression model, impaired LV function [(p=0.02), hazard ratio 0.25 (95% confidence intervals (C.I.) 0.078-0.84)] and AF [(p=0.03), hazard ratio 2.70 (95% C.I. 1.09-6.68)] were significant adverse predictors of survival.
CONCLUSIONS: This study shows that in patients undergoing MV repair for degenerative MR, preoperative AF has a major negative impact on the early and late survival.

Entities:  

Mesh:

Year:  2007        PMID: 17280837     DOI: 10.1016/j.ejcts.2006.12.039

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 2.  Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis.

Authors:  Siddharth Shah; Vijay Raj; Mahmoud Abdelghany; Carlos Mena-Hurtado; Sana Riaz; Siddharth Patel; Howard Wiener; Debanik Chaudhuri
Journal:  Heart Fail Rev       Date:  2020-11-10       Impact factor: 4.214

3.  Mitral annulus morphologic and functional analysis using real time tridimensional echocardiography in patients submitted to unsupported mitral valve repair.

Authors:  Marco Antônio Vieira Guedes; Pablo Maria Alberto Pomerantzeff; Carlos Manuel de Almeida Brandão; Marcelo Luiz Campos Vieira; Flávio Tarasoutchi; Pablo da Cunha Spinola; Fábio Biscegli Jatene
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

4.  Impact of paroxysmal versus non-paroxysmal atrial fibrillation on outcomes in patients undergoing transcatheter mitral valve repair.

Authors:  Kishorbhai Gangani; Haytham Alkhaimy; Nikita Patil; Kranthi Sitammagari; Poonam Bhyan; Sameer Arora; John P Vavalle
Journal:  Cardiovasc Diagn Ther       Date:  2020-02

Review 5.  Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.

Authors:  Jean Jacques Noubiap; Ulrich Flore Nyaga; Aude Laetitia Ndoadoumgue; Jan René Nkeck; Anderson Ngouo; Jean Joel Bigna
Journal:  Glob Heart       Date:  2020-05-18

6.  Impact of atrial fibrillation on outcomes of patients treated by transcatheter mitral valve repair: A systematic review and meta-analysis.

Authors:  Fuqiang Sun; Honghao Liu; Qi Zhang; Fanfan Lu; Haibo Zhan; Jiawei Zhou
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.